Last updated on March 2017

Study Seeking Patients with Schizophrenia


Brief description of study

Study Seeking Patients with Schizophrenia

Detailed Study Description

A Randomized, Open-label, Multiple-dose, Parallel Design, Comparative Bioequivalence Study of Paliperidone Palmitate Extended-Release Injectable Suspension (156 mg/1.0 mL) Versus Invega Sustenna® (paliperidone palmitate) Extended-Release Injectable Suspension (156mg/1.0 mL) in Schizophrenia Patients Already Stabilized on Paliperidone Palmitate

Clinical Study Identifier: TX148352

Find a site near you

Start Over

Segal Institute for Clinical Research

1201 North 37th Avenue Hollywood, FL USA
  Connect »